22 May 2013
Keywords: bayer, reports, strong, results, leukine, trial, germany
Article | 16 June 2008
Germany's Bayer HealthCare reported positive data from a Phase II study of its Leukine (sargamostim) as an adjuvant treatment for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 June 2008
16 June 2008
21 May 2013
© 2013 thepharmaletter.com